Is strattera an amphetamine

Similarities, differences, and how to choose

The Food and Drugs Administration have approved Strattera and Vyvanse to treat attention deficit hyperactivity disorder in children and adults.

Strattera (atomoxetine) and Vyvanse (lisdexamfetamine) have different mechanisms of action to treat attention deficit hyperactivity disorder (ADHD). Strattera is a nonstimulant drug while Vyvanse is a stimulant. There are some differences in their side effects, dosages, risks, and drug interactions.

This article looks at the similarities and differences between Strattera and Vyvanse to help people make decisions about treatment for ADHD.

Share on PinterestA doctor may prescribe Strattera to treat ADHD.
Image credit: gloom 2010

Atomoxetine, the active ingredient in Strattera, is the best known nonstimulant medication to treat ADHD.

Strattera is technically an antidepressant drug, which doctors classify as a selective norepinephrine reuptake inhibitor (SNRI). Doctors prescribe other SNRI medications to treat depression, but they only prescribe Strattera to treat ADHD.

Strattera works by changing the way a person’s brain uses norepinephrine, which is a neurotransmitter, or brain chemical. Norepinephrine affects a person’s ability to pay attention. Strattera acts on this system to help improve a person’s attention span.

Although nonstimulant medications, such as Strattera, are effective for treating ADHD, they do not work as well as stimulant drugs. They are, however, a better choice for people who do not tolerate stimulants well or have problems with anxiety, which stimulants can adversely affect.

Vyvanse is a stimulant medication belonging to the amphetamine subgroup. Like Strattera, Vyvanse also affects how the brain uses neurotransmitters.

Vyvanse and other amphetamines block the reuptake of norepinephrine and dopamine in the brain. Dopamine is a neurotransmitter connected to mood, attention, and motivation.

Researchers believe low levels of dopamine and the symptoms of ADHD are linked. Therefore, Vyvanse can help improve the way the brain uses dopamine to assist with symptoms related to attention or motivation.

People also take Vyvanse for the treatment of binge eating disorder in adults.

Doctors classify Vyvanse and other stimulant medications for ADHD as Schedule II drugs, meaning they have a high potential for abuse.

Adults and children aged 6 years or older can take Strattera or Vyvanse to help manage the symptoms of ADHD.

Typically, a doctor will start a person on the lowest dose of medication and gradually increase the dosage as appropriate. Factors such as age and weight will influence the dose a person takes.

People can take both medications with or without food. Taking Vyvanse in the morning will help a person avoid insomnia at night.

Strattera and Vyvanse both come in capsule form. Vyvanse also comes in chewable tablets.


Strattera capsules come in the following doses:

  • 10 mg
  • 18 mg
  • 25 mg
  • 40 mg
  • 60 mg
  • 80 mg
  • 100 mg

The dosage varies depending on a person’s body weight and age.

Children who weigh less than 70 kilograms (kg) should start Strattera at a dose of 0.5 milligrams per kilogram of body weight (mg/kg) and increase this to a target total daily dose of 1.2 mg/kg per day.

Children and adolescents should not take more than 1.4 mg/kg or 100 mg (whichever is less).

Children who weigh more than 70 kg and adults can start at a dose of 40 mg per day and increase this to a target dose of 80 mg per day. After 2–4 weeks, people can increase to 100 mg daily if they have not achieved an ideal response. This dose is the maximum daily dose.

People should swallow the capsules whole rather than breaking them apart.

Typically, people do not need to taper Strattera before discontinuing.


Share on PinterestVyvanse comes in the form of both capsules and chewable tablets.

Vyvanse capsules come in the following doses:

  • 10 mg
  • 20 mg
  • 30 mg
  • 40 mg
  • 50 mg
  • 60 mg
  • 70 mg

Vyvanse chewable tablets come in the following doses:

  • 10 mg
  • 20 mg
  • 30 mg
  • 40 mg
  • 50 mg
  • 60 mg

People aged 6 and over can start taking 30 mg of Vyvanse daily. A doctor may increase the dosage by 10 or 20 mg every week to achieve the desired response. The maximum daily dose is 70 mg daily. The recommended dose is 30–70 mg.

People who take Vyvanse for binge eating disorder also start on an initial dose of 30 mg. They can increase this by 20 mg a week up to a maximum of 70 mg. The recommended dose is 30–70 mg.

People can swallow Vyvanse capsules whole or open the capsule and mix the powder with yogurt, juice, or water.

Vyvanse chewable tablets contain a dosage that is equivalent to the capsule. A person should chew the tablet thoroughly before swallowing.

Strattera and Vyvanse appear to have similar side effect profiles. Although Strattera may also lead to side effects of sexual dysfunction.

Common side effects of Strattera include:

  • abdominal pain
  • nausea
  • vomiting
  • fatigue
  • irritability
  • weight loss
  • poor appetite
  • headache
  • sleepiness
  • dizziness
  • rash
  • heart racing
  • dry mouth
  • constipation
  • chills
  • numbness and tingling
  • insomnia
  • trouble urinating
  • erectile dysfunction or ejaculation disorder
  • increased sweating or hot flashes

Common side effects of Vyvanse include:

  • decreased appetite
  • difficulty sleeping
  • abdominal pain
  • irritability
  • vomiting
  • weight loss
  • nausea
  • dry mouth
  • dizziness
  • rash
  • heart racing
  • tremor
  • diarrhea
  • anxiety
  • agitation
  • increased sweating
  • shortness of breath

There are some risks a person should be aware of when considering Strattera or Vyvanse.

Since Vyvanse contains a stimulant, it carries a high risk of abuse and dependence.

Both Strattera and Vyvanse have the potential to cause sudden cardiac death and raise blood pressure or heart rate. People who have known underlying heart problems should avoid these medications.

Both Strattera and Vyvanse can induce psychotic symptoms, including hallucinations or mania in children and adolescents, even in those without a known history of psychotic disorder.

Additionally, Strattera has links to an increased risk of suicidal thoughts in children and adolescents. A doctor should monitor people who begin taking Strattera or Vyvanse for changes in behavior.

Strattera and Vyvanse may interfere with growth and weight in children, and therefore, a doctor should monitor the child’s growth.

Suicide prevention

If you know someone at immediate risk of self-harm, suicide, or hurting another person:

  • Ask the tough question: “Are you considering suicide?”
  • Listen to the person without judgment.
  • Call 911 or the local emergency number, or text TALK to 741741 to communicate with a trained crisis counselor.
  • Stay with the person until professional help arrives.
  • Try to remove any weapons, medications, or other potentially harmful objects.

If you or someone you know is having thoughts of suicide, a prevention hotline can help. The 988 Suicide and Crisis Lifeline is available 24 hours a day at 988. During a crisis, people who are hard of hearing can use their preferred relay service or dial 711 then 988.

Click here for more links and local resources.

Strattera and Vyvanse may interact with certain medications. A person should always tell their doctor about all of the other medicines they take, including over-the-counter (OTC) medicines, supplements, and herbal remedies.

Strattera and Vyvanse may interact with other medications used for depression, including monoamine oxidase reuptake inhibitors (MAOIs), serotonergic drugs, and tricyclic antidepressants (TCAs).

Some medications, including quinidine and ritonavir, can affect the metabolism of Strattera or Vyvanse, resulting in higher levels of the drug in the body.

Share on PinterestA doctor can explain the benefits, risks, and side effects of either drug.

Both medications are effective in improving the symptoms of ADHD.

Stimulants like Vyvanse are the most common drug for treating ADHD. However, nonstimulant medications such as Strattera may be a better option for some people, especially those who are not able to tolerate stimulants.

A person should talk to their doctor about the benefits, risks, and side effects of taking different ADHD medications. The doctor will develop an individualized treatment plan to fit what is best for that person.

Strattera and Vyvanse are medications that treat the symptoms of ADHD. Vyvanse contains amphetamine, which is a stimulant. Strattera does not contain a stimulant. Children over the age of 6, as well as adults, can take these medications.

The two medications have different mechanisms of action to treat ADHD. They also carry individual risks and side effects.

People should discuss with their doctor to determine the most appropriate treatment for ADHD symptoms.


Is it safe to take Strattera and Vyvanse together?


Strattera and Vyvanse do not have a direct drug interaction, but it is not common to take both together. However, there are some situations when someone might be taking both. Strattera has a delayed onset of action, and a person might take Vyvanse to help bridge or treat their ADHD symptoms while the Strattera takes effect. Once the Strattera has time to start working, the person would stop using Vyvanse and continue only taking the Strattera.

Dena Westphalen, PharmDAnswers represent the opinions of our medical experts. All content is strictly informational and should not be considered medical advice.

ADHD Medications: Strattera, Antidepressants & More

There are many drugs other than psychostimulants that can be used to treat ADHD.

Nonstimulant therapy

Strattera® (atomoxetine) is the first nonstimulant medication approved by the Food and Drug Administration (FDA) for the treatment of attention-deficit/hyperactivity disorder (ADHD). Strattera and all the other nonstimulants are generally considered to be less effective than psychostimulants in treating ADHD. The nonstimulants are usually considered second- and third-line medications.

Strattera works on the neurotransmitter (chemical in the brain that transmits nerve impulses) called norepinephrine. Like the stimulant drugs, Strattera is effective in treating and controlling ADHD symptoms. Unlike stimulant drugs, Strattera is not a controlled substance. Therefore, people are less likely to abuse or become dependent on it.

In addition, Strattera doesn't cause many of the potential side effects linked to psychostimulants, such as sleeplessness. Strattera can cause very significant abdominal pain, nausea and drowsiness, especially when starting the medication. Strattera tends to offset the effect of the stimulant starting to work and then wearing off. At times, it still should be taken more than once a day.

How does Strattera work?

This medication works by increasing the amount of norepinephrine, an important chemical in the brain. Doing this appears to help ADHD by increasing attention span and reducing impulsive behavior and hyperactivity.

Who should not take Strattera?

There are certain situations in which you shouldn't take Strattera. If you or your child has any of the following conditions, you should inform your healthcare provider before taking Strattera:

  • Allergy to Strattera or any of its components.
  • Narrow angle glaucoma (a condition that causes increased pressure in the eyes and can lead to blindness).
  • Treatment with a type of medication called monoamine oxidase inhibitors (MAOIs), such as Nardil® (phenelzine), Parnate® (tranylcypromine), Marplan® (isocarboxazid) or Emsam® (selegeline transdermal system) within 14 days of starting Strattera.
  • An adrenal problem called pheochromocytoma or a history of this condition.
  • Severe heart disease.

What are the side effects of Strattera?

The most common side effects in children and adolescents are:

  • Upset stomach (e.g., nausea, vomiting).
  • Decreased appetite, which may cause weight loss.
  • Nausea.
  • Dizziness.
  • Headache.
  • Mood swings.
  • Insomnia.
  • Drowsiness.
  • Abdominal pain.

The most common side effects in adults are:

  • Constipation.
  • Dry mouth.
  • Insomnia.
  • Erectile dysfunction.
  • Urinary tract abnormalities (e.g., trouble passing urine, pain with urination).
  • Painful menstruation.
  • Hot flashes.

These side effects can be significant and may require stopping the medication.

However in most cases, these side effects are generally not severe. Only a very small percentage of patients needed to stop Strattera due to side effects experienced during clinical trials.

Allergic reactions to Strattera are rare but do occur, usually as swelling or hives. Tell your provider right away if you or your family member taking Strattera develops a skin rash, swelling, hives or other allergic symptoms.

There have been reports of slightly decreased growth in children and teens taking Strattera. It's recommended that children and adolescents be observed, measured and weighed periodically while on Strattera.

Strattera should be stopped if you have signs of jaundice — yellowing of the skin or whites of the eyes. Jaundice is a sign of liver damage. Itching, right upper belly pain, dark urine and unexplained flu-like symptoms may also be signs of liver injury. If blood tests show evidence of liver damage, stop taking Strattera.

Strattera can increase suicidal thinking in teens who take the drug. Patients should be monitored for suicidal thoughts and actions while taking Strattera®.

Strattera can cause serious heart-related complications (e. g., heart attack, stroke), high blood pressure and increased heart rate especially if you have a history of heart and/or vessel disease and/or irregular heart rate. Therefore, patients should be evaluated for heart disease prior to starting Strattera and be monitored for changes in blood pressure and heart rate during therapy.

Strattera should be discontinued if symptoms of psychosis (such as hearing voices, believing things that are not true, being suspicious) or mania occur.

Aggressive or hostile behavior may occur. Therefore, monitoring for this type of behavior during Strattera therapy is recommended.

This is not a complete list of all side effects. If you have questions about side effects, please contact your healthcare provider.

Be sure to tell your healthcare provider:

  • If you are nursing, pregnant or plan to become pregnant.
  • If you are taking or plan to take any prescription drugs (especially antidepressants or other psychiatric medicines, blood pressure medicines, linezolid or methylene blue), dietary supplements, herbal medicines or nonprescription medications (especially cough and cold medicines that contain decongestants or nonsteroidal anti-inflammatory medicines like ibuprofen or naproxen).
  • If you have any past or present medical problems, including high blood pressure, seizures, heart disease, glaucoma or liver or kidney disease.
  • If you have a history of drug or alcohol abuse or dependency or if you have had mental health problems, including depression, manic depression or psychosis.
  • If you have had any liver problems or jaundice in the past.
  • If you become agitated or irritable or if you develop ideas of hurting yourself.

Take Strattera exactly as prescribed by your healthcare provider. It's usually taken once or twice a day and may be taken with or without food. Your physician may adjust the dose until it's correct for you or your child. No specific laboratory testing is required while taking Strattera. It may be used for extended or long-term treatment as long as there are periodic evaluations with your healthcare provider.

Is antidepressant therapy used to treat ADHD?

Several types of antidepressant drugs can be used to treat ADHD. Antidepressant therapy for ADHD is sometimes used as the treatment of choice for children or adults who have ADHD and depression.

Antidepressants, however, are generally not as effective as stimulants or Strattera at improving attention span and concentration.

Antidepressants used for treating ADHD include the following:

  • Tricyclic antidepressants, such as Pamelor™ (nortriptyline), Tofranil® (imipramine) and Norpramin® (desipramine) have been shown to be helpful in children and adults with ADHD, but they can cause some unpleasant side effects, such as dry mouth, constipation or urinary problems. They are also relatively inexpensive.
  • Wellbutrin® (bupropion), a different type of antidepressant, has been found to be effective in treating ADHD in adults and children. It's generally well-tolerated, but it also has some side effects that may be a problem for some people who have anxiety, headaches or seizures.
  • Effexor® (venlafaxine) and Effexor XR® (venlafaxine extended-release) are newer antidepressants that increase the levels of norepinephrine and serotonin in the brain. The drugs are effective at improving mood and concentration in adults as well as children and teens. They are occasionally used to treat ADHD.
  • Monoamine oxidase inhibitors (MAOIs) are a group of antidepressants that can treat ADHD with some benefit, but are rarely used because they have significant and sometimes serious side effects and can dangerously interact with certain foods and other medications. They may be of benefit in situations when other medications have failed. Examples include Nardil (phenelzine), Parnate (tranylcypromine), Marplan (isocarboxazid) or Emsam (selegeline transdermal system). Monoamine oxidase inhibitors are generally not prescribed for children or teens.

Note: The FDA has determined that antidepressant medications increase the risk of suicidal thinking and behavior in children and adolescents with depression and other psychiatric disorders. If you have questions or concerns, please discuss them with your healthcare provider.

How do antidepressants work?

Since most antidepressants work by increasing the levels of brain messenger chemicals (neurotransmitters), such as norepinephrine, serotonin and dopamine, it makes sense that they might have effects similar to other ADHD stimulant and nonstimulant treatments that appear to work by similar mechanisms.

Antidepressant treatment can have a small effect on attention span as well as impulse control, hyperactivity and aggressiveness. Children and adolescents treated with antidepressants are often more willing to take direction and may be less disruptive.

Antidepressants have the advantage of a low potential for abuse and there is no evidence that they suppress growth or contribute to significant weight loss.

Who should not take antidepressants?

Antidepressants should not be used in the following situations:

  • If you have a history or tendency toward manic behavior or manic depression (bipolar disorder).
  • Wellbutrin (bupropion) should not be taken if you have any history of seizures or epilepsy.
  • Treatment with antidepressants should not be initiated if you have taken a MAO inhibitor antidepressant, such as Nardil, Parnate. Marplan or Emsam within the last 14 days.

Each type of antidepressant has its own contraindications and usage warnings; you should discuss these with your healthcare provider.

The most common side effects experienced with tricyclic antidepressants include:

  • Stomach upset.
  • Constipation.
  • Dry mouth.
  • Blurred vision.
  • Drowsiness.
  • Dizziness.
  • Low blood pressure.
  • Weight gain.
  • Tremor.
  • Sweating.
  • Difficulty urinating.

Some tricyclic antidepressants are more likely to cause particular side effects than others.

Tricyclic antidepressants are potentially lethal in the event of an overdose of medication.

Tricyclic antidepressants also have the potential to cause serious heart conduction defects. Periodic electrocardiogram (EKG) monitoring is recommended during tricyclic antidepressant therapy to look for these heart problems.

Wellbutrin sometimes causes stomach upset, anxiety, headaches and rashes.

Effexor and Effexor XR can cause nausea, anxiety, sleep problems, tremor, dry mouth and sexual problems in adults.

Monoamine oxidase inhibitors can cause a wide variety of side effects, including dangerously increased blood pressure when combined with certain foods or medications. Prior to starting MAOI therapy, please consult a healthcare professional concerning potential food and drug interactions.

This is not a complete list of all side effects for antidepressants. If you have questions about side effects, please contact your healthcare provider.

When taking antidepressants for ADHD, be sure to tell your healthcare provider:

  • If you are nursing, pregnant or plan to become pregnant.
  • If you are taking or plan to take any prescription drugs, dietary supplements, herbal medicines or nonprescription medications.
  • If you have any past or present medical problems, including high blood pressure, seizures, heart disease and urinary problems.
  • If you have a history of drug or alcohol abuse or dependency or if you have had mental health problems, including depression, manic depression or psychosis.
  • If you develop any depressive symptoms or feelings that you might harm yourself.
  • If you develop irregular heartbeats (heart palpitations) or fainting spells.

The following are useful guidelines to keep in mind when taking antidepressants or giving them to your child for ADHD:

  • Always give the medication exactly as prescribed. If there are any problems or questions, call your healthcare provider.
  • Consult your physician prior to discontinuing antidepressant therapy.
  • Antidepressants usually take 2-4 weeks before the full effects are apparent. Be patient and don’t give up before giving them a chance to work.
  • Your provider will probably want to start your medication at a low dose and increase gradually until symptoms are controlled.
  • It's better not to miss doses of antidepressants. Most are given once or twice a day. If you miss a day or two of Effexor, it can cause an unpleasant withdrawal syndrome.
  • Taking bulk laxatives (fiber) and drinking lots of water is a good idea with tricyclic antidepressants, as they tend to cause constipation and hard stools.
  • Tell your provider if you notice any new or unusual side effects.

What other nonstimulant therapies are used to treat ADHD?

Two drugs, Kapvay® (extended-release clonidine) and Intuniv® (extended-release guanfacine), have been approved by the FDA for use alone or with stimulant drugs for the treatment of ADHD. These drugs can improve mental functioning as well as behavior in people with ADHD. However, they are usually reserved for those who respond poorly to and cannot tolerate stimulants or Strattera.

Clonidine is also available as a short-acting tablet and as a transdermal patch. Guanfacine is also available as a short-acting tablet. These dosage forms have also been used to treat ADHD, however they are not specifically approved by the FDA for this indication.

How do these drugs treat ADHD?

How these drugs work in treating ADHD is not yet known, but it is clear that they have a calming effect on certain areas of the brain.

Who should not take these drugs?

Kapvay should not be used in patients who are allergic to clonidine (e. g., Catapres®). Intuniv should not be used in patients who are allergic to guanfacine (e.g., Tenex®).

What are the side effects of these drugs?

The most common side effects include:

For Kapvay:

  • Drowsiness.
  • Headache.
  • Irritability.
  • Insomnia.
  • Nightmares.
  • Change in mood.
  • Dry mouth.

For Intuniv:

  • Drowsiness.
  • Headache.
  • Nausea.
  • Weakness.
  • Stomach pain.
  • Dizziness.

These drugs can rarely cause irregular heartbeats. They can lower blood pressure and slow heart rate.

Careful screening for heart rhythm irregularities and regular monitoring of blood pressure and EKGs is recommended.

Both drugs can cause significant drowsiness; use caution when operating dangerous equipment or driving until you know how these drugs affect you.

This is not a complete list of side effects. If you experience a potential side effect while taking these drugs, please consult a healthcare professional.

Are there tips and precautions for nonstimulant medications in ADHD treatment?

When taking one of these drugs for ADHD, be sure to tell your healthcare provider:

  • If you are nursing, pregnant or plan to become pregnant.
  • Consult your provider before discontinuing therapy; Kapvay and Intuniv should not be abruptly discontinued.
  • If you are taking or plan to take any prescription drugs, dietary supplements, herbal medicines or nonprescription medications.
  • If you have any past or present medical problems, including low blood pressure, seizures, heart rhythm disturbances and urinary problems.
  • If you develop irregular heartbeats (heart palpitations) or fainting spells.

The following are useful guidelines to keep in mind when taking clonidine or guanfacine or giving them to your child for ADHD:

  • Always take or give the medication exactly as prescribed. If there are any problems or questions, call your provider. It is best not to miss doses as this may cause the blood pressure to rise quickly, which may cause headaches and other symptoms.
  • Your health care provider will probably want to start the medication at a low dose and increase gradually until symptoms are controlled.
  • For very young children, clonidine short-acting tablets can be formulated into a liquid by a compounding pharmacy to make it easier to give the medication. Short-acting clonidine tablets can be crushed and mixed with food if necessary. However, Kapvay which is a long-acting clonidine tablet should not be chewed, crushed or broken.
  • Intuniv, which is a long-acting guanfacine, should not be chewed, crushed or broken.
  • Do not stop clonidine therapy, including Kapvay or guanfacine, including Intuniv, suddenly since this can cause a rebound increase in blood pressure. These medications must be tapered.

Treatments for ADHD | Neuroapex

There are currently several approaches to the treatment of ADHD .

Drug therapy .

In world practice, the main group of drugs for the correction of ADHD symptoms in hyperactive children are psychostimulants. The most famous of these are methylphenidate (trade name Ritalin), dextroamphetamine with amphetamine, and dextroamphetamine. One of the disadvantages of these drugs is the need to take them several times a day (the duration of action is about 4 hours). Now there are methylphenidate and dextroamphetamine with long-acting amphetamine (up to 12 hours). Other groups of drugs are also used, for example, atomoxetine, struttera, etc. However, the most serious side effect is due to the fact that Ritalin is in the same group with cocaine in terms of its pharmacological properties and has much in common with it. In the United States, Ritalin is actively used in the illegal soft drug market. According to available data, long-term use of Ritalin increases the risk of drug addiction in hyperactive children by several times.

An approach common in the CIS is nootropic drugs, substances that improve brain function, metabolism, energy, and increase the tone of the cortex. Also prescribed drugs, consisting of amino acids, which improve the metabolism of the brain. However, evidence of the effectiveness of these drugs to date does not exist, and those positive results noted by individual patients are apparently associated with a placebo effect. In general, the impact of both psychostimulants and new drugs for the correction of ADHD is aimed at brain neurotransmitters - dopamine, serotonin, etc. Assessing the possibilities of drug therapy for ADHD in general, the following should be noted. Firstly, pharmacotherapy is a symptomatic treatment, i.e. suppression of symptoms due to continuous use of the drug. Even long-term use of the drug does not correct the brain anomalies that cause ADHD behavior, since, according to available data, discontinuation of the drug, even after many years of constant use, leads to a return within 1-2 months of the original ADHD symptoms. Secondly, all psychostimulants, including Ritalin, have such side effects that cast doubt on the justification and expediency of their use.

Neuropsychological approach .

The essence of the approach lies in the fact that with the help of various exercises we return to the previous stages of ontogenesis and rebuild those functions that were formed archaically incorrectly and have already been fixed. To do this, they need, like any other ineffective pathological skill, to purposefully reveal, disinhibit, destroy and create a new skill that is more consistent with effective work. This is a laborious, multi-month job. The child is born 9months. And neuropsychological correction is designed for this period. And then the brain begins to work more efficiently, with less energy costs. However, conclusive evidence of the effectiveness of this approach in accordance with the criteria of evidence-based medicine does not currently exist.

Behavioral or Behavioral Therapy focuses on patterns of behavior, either shaping or suppressing them through reward, punishment, coercion, and inspiration.

Work on personality. Family therapy , which forms the personality and which determines where to direct these qualities (disinhibition, aggressiveness, increased activity).

Neurotherapy or Biofeedback (BFB) .

Biofeedback therapy is a very young area of ​​neuroscience and medicine. In Russia, the biofeedback method is not formally an official medical method of treatment, it is not taught in medical universities, it is not certified and retrained, there is no licensing system. And this means that it is almost impossible to determine the level of professional training of a specialist engaged in biofeedback therapy for a client-patient.

At its core, biofeedback therapy is a procedure of the so-called instrumental conditioned reflex training (or conditioning) in relation to certain rhythms of the electroencephalogram (EEG) of the human brain. Such learning manifests itself in a gradual change in the “trained” parameter of the EEG rhythm, either upward (for example, an increase in the beta rhythm or alpha rhythm) or downward (for example, a decrease in the theta rhythm), which leads to an improvement or normalization of the functioning of the “trained ” areas of the cerebral cortex, which, in turn, leads to the expected improvement in behavioral and clinical indicators - an improvement in the function of attention, working memory, emotional self-regulation, the ability to plan and predict, and the level of self-esteem.


dangerous drug Attorneys Gregory Krasovsky Law Office can provide legal advice and representation for individuals and families considering a Strattera lawsuit. In order for the plaintiff to secure the maximum settlement in a Strattera litigation claim, whether in an individual lawsuit or in a lawsuit, it is extremely important that the law firm representing you has a competent and experienced team of Strattera lawyers to guide you through all legal hurdles as well as direct you to sufficient funding (lawsuit funding or legal finance) to cover pharmaceutical legal costs. Contact a Strattera attorney today to schedule a free consultation and take the first step towards getting reimbursed for losses caused by Stattera side effects.

Strattera, commonly known as Atomoxetine, was approved by the US Food and Drug Administration (FDA) in 2002 for use as a treatment for attention deficit hyperactivity disorder (ADHD) and attention deficit disorder (ADD), which has since pore relabeled ADHD. Strattera, unlike amphetamine-like Adderall and Ritalin, is a selective norepinephrine reuptake inhibitor (SNRI). This means that Strattera has less potential for abuse than Adderall, Concerta, Dexedrine, and Ritalin. Strattera is marketed by Eli Lilly and is required to carry a black box warning due to serious side effects of Strattera, namely liver damage and suicidal tendencies.

In September 2005, the FDA issued a health advisory about Strattera after Eli Lilly presented results from clinical trials. These results indicated that adolescents and young adults have an increased tendency to have suicidal thoughts as a result of taking Strattera. Although no suicides have been reported so far, there have been cases of suicide attempts stemming from the use of Strattera. Strattera was originally developed as an antidepressant, but was found to have no positive effect on depression, so Eli Lilly decided to market his worried parents, who would be easily convinced to feed the mind-altering substance to their children.
In the direction of increased suicidal tendencies, Strattera can also cause severe liver damage. In 2004, the FDA ruled that Strattera had a black box warning regarding its potential to cause severe liver damage and jaundice. Physicians are advised to discontinue prescribing Strattera to patients who exhibit symptoms of the above conditions. Indeed, Strattera-induced liver injury can lead to liver failure, which can then lead to death or liver transplantation.
Strattera side effects include, but are not limited to them, the following:
damage to the liver
Liver Refusal
Sexual Problems
Libido Libido
Suicidal thoughts
Suinite Culti-Cults
Hardias Cultsion
Caliacies 9004 Superior Cultiches 9004 thinking
Suicidal behavior
Increased heart rate
High blood pressure
Heart attack
In England, Strattera is on the Triangle drug blacklist, which includes drugs under severe surveillance for severe adverse reactions.

Learn more